Cargando…

Non-Invasive Assessment of Hypoxia and Neovascularization with MRI for Identification of Aggressive Breast Cancer

The aim of this study was to investigate the potential of magnetic resonance imaging (MRI) for a non-invasive synergistic assessment of tumor microenvironment (TME) hypoxia and induced neovascularization for the identification of aggressive breast cancer. Fifty-three female patients with breast canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bennani-Baiti, Barbara, Pinker, Katja, Zimmermann, Max, Helbich, Thomas H., Baltzer, Pascal A., Clauser, Paola, Kapetas, Panagiotis, Bago-Horvath, Zsuzsanna, Stadlbauer, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464174/ https://www.ncbi.nlm.nih.gov/pubmed/32721996 http://dx.doi.org/10.3390/cancers12082024

Ejemplares similares

Clinical relevance of total choline (tCho) quantification in suspicious lesions on multiparametric breast MRI
por: Sodano, Claudia, et al.
Publicado: (2020)

An A.I. classifier derived from 4D radiomics of dynamic contrast-enhanced breast MRI data: potential to avoid unnecessary breast biopsies
por: Pötsch, Nina, et al.
Publicado: (2021)

Virtual Touch IQ elastography reduces unnecessary breast biopsies by applying quantitative “rule-in” and “rule-out” threshold values
por: Kapetas, Panagiotis, et al.
Publicado: (2018)

A Simple Ultrasound Based Classification Algorithm Allows Differentiation of Benign from Malignant Breast Lesions by Using Only Quantitative Parameters
por: Kapetas, Panagiotis, et al.
Publicado: (2018)

Simultaneous 18F-FDG PET/MRI Radiomics and Machine Learning Analysis of the Primary Breast Tumor for the Preoperative Prediction of Axillary Lymph Node Status in Breast Cancer
por: Romeo, Valeria, et al.
Publicado: (2023)

A Simultaneous Multiparametric (18)F-FDG PET/MRI Radiomics Model for the Diagnosis of Triple Negative Breast Cancer
por: Romeo, Valeria, et al.
Publicado: (2022)

Breast lesion detection and characterization with contrast‐enhanced magnetic resonance imaging: Prospective randomized intraindividual comparison of gadoterate meglumine (0.15 mmol/kg) and gadobenate dimeglumine (0.075 mmol/kg) at 3T
por: Clauser, Paola, et al.
Publicado: (2018)

Is the Level of Contrast Enhancement on Contrast-Enhanced Mammography (CEM) Associated with the Presence and Biological Aggressiveness of Breast Cancer?
por: Marzogi, Alaa, et al.
Publicado: (2023)

Sequential [(18)F]FDG-[(18)F]FMISO PET and Multiparametric MRI at 3T for Insights into Breast Cancer Heterogeneity and Correlation with Patient Outcomes: First Clinical Experience
por: Andrzejewski, Piotr, et al.
Publicado: (2019)

Density and tailored breast cancer screening: practice and prediction – an overview
por: Wengert, Georg J, et al.
Publicado: (2018)

Can supplementary contrast-enhanced MRI of the breast avoid needle biopsies in suspicious microcalcifications seen on mammography? A systematic review and meta-analysis
por: Fueger, Barbara J., et al.
Publicado: (2021)

Diffusion‐weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer
por: Horvat, Joao V., et al.
Publicado: (2019)

Low‐Dose, Contrast‐Enhanced Mammography Compared to Contrast‐Enhanced Breast MRI: A Feasibility Study
por: Clauser, Paola, et al.
Publicado: (2020)

A simple classification system (the Tree flowchart) for breast MRI can reduce the number of unnecessary biopsies in MRI-only lesions
por: Woitek, Ramona, et al.
Publicado: (2017)

The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening exams
por: Milos, Ruxandra Iulia, et al.
Publicado: (2020)

AI-enhanced simultaneous multiparametric (18)F-FDG PET/MRI for accurate breast cancer diagnosis
por: Romeo, V., et al.
Publicado: (2021)

Breast MRI: does a clinical decision algorithm outweigh reader experience?
por: Pötsch, Nina, et al.
Publicado: (2022)

Limited role of DWI with apparent diffusion coefficient mapping in breast lesions presenting as non-mass enhancement on dynamic contrast-enhanced MRI
por: Avendano, Daly, et al.
Publicado: (2019)

Impact of the Kaiser score on clinical decision-making in BI-RADS 4 mammographic calcifications examined with breast MRI
por: Wengert, G. J., et al.
Publicado: (2019)

MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer
por: Bennani-Baiti, Barbara, et al.
Publicado: (2016)

Correction: MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer
por: Bennani-Baiti, Barbara, et al.
Publicado: (2016)

MRI for the assessment of malignancy in BI-RADS 4 mammographic microcalcifications
por: Bennani-Baiti, Barbara, et al.
Publicado: (2017)

One view or two views for wide-angle tomosynthesis with synthetic mammography in the assessment setting?
por: Clauser, Paola, et al.
Publicado: (2021)

MR-guided vacuum-assisted breast biopsy of MRI-only lesions: a single center experience
por: Spick, Claudio, et al.
Publicado: (2016)

New diagnostic tools for breast cancer
por: Baltzer, Pascal A. T., et al.
Publicado: (2017)

Diagnostic Performance of Breast Magnetic Resonance Imaging in Non-Calcified Equivocal Breast Findings: Results from a Systematic Review and Meta-Analysis
por: Bennani-Baiti, Barbara, et al.
Publicado: (2016)

Prospective validation of 18F-Fluoroethylcholine as a tracer in PET/MRI for the evaluation of breast lesions and prediction of lymph node status
por: Clauser, Paola, et al.
Publicado: (2023)

Inter- and intra-observer agreement of BI-RADS-based subjective visual estimation of amount of fibroglandular breast tissue with magnetic resonance imaging: comparison to automated quantitative assessment
por: Wengert, G. J., et al.
Publicado: (2016)

A survey by the European Society of Breast Imaging on the utilisation of breast MRI in clinical practice
por: Clauser, Paola, et al.
Publicado: (2017)

A multiparametric [(18)F]FDG PET/MRI diagnostic model including imaging biomarkers of the tumor and contralateral healthy breast tissue aids breast cancer diagnosis
por: Leithner, Doris, et al.
Publicado: (2019)

Introduction of a breast apparent diffusion coefficient category system (ADC-B) derived from a large multicenter MRI database
por: Bickel, Hubert, et al.
Publicado: (2023)

Automatic segmentation and classification of breast lesions through identification of informative multiparametric PET/MRI features
por: Vogl, Wolf-Dieter, et al.
Publicado: (2019)

Changes in Tumor Biology During Chemoradiation of Cervix Cancer Assessed by Multiparametric MRI and Hypoxia PET
por: Georg, Petra, et al.
Publicado: (2017)

Diffusion‐Weighted MRI of Breast Cancer: Improved Lesion Visibility and Image Quality Using Synthetic b‐Values
por: Bickel, Hubert, et al.
Publicado: (2019)

External Validation of a Risk Stratification Score for B3 Breast Lesions Detected at Ultrasound Core Needle Biopsy
por: Grippo, Cristina, et al.
Publicado: (2020)

Breast PET/MRI Hybrid Imaging and Targeted Tracers
por: Romeo, Valeria, et al.
Publicado: (2022)

Investigating the prediction value of multiparametric magnetic resonance imaging at 3 T in response to neoadjuvant chemotherapy in breast cancer
por: Minarikova, Lenka, et al.
Publicado: (2016)

Multimodality Imaging of Breast Parenchymal Density and Correlation with Risk Assessment
por: Wengert, Georg J., et al.
Publicado: (2019)

Breast Lesion Classification with Multiparametric Breast MRI Using Radiomics and Machine Learning: A Comparison with Radiologists’ Performance
por: Daimiel Naranjo, Isaac, et al.
Publicado: (2022)

Cancer Bioinformatic Methods to Infer Meaningful Data From Small-Size Cohorts
por: Bennani-Baiti, Nabila, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ed2ojjr6pi7n1u3vdrl8t2h1ng